Paolo Tombesi Net Worth & Insider Trades
Paolo Tombesi - Chief Financial Officer, Epizyme, Inc
What is Paolo Tombesi's Net Worth?
The current estimated net worth of Epizyme, Inc's Chief Financial Officer, Paolo Tombesi, is estimated to be about $1.38M . Paolo Tombesi owns about 53,465 units of Epizyme, Inc common stock. In the last 2 years at Epizyme, Inc, Paolo Tombesi has sold an estimated value of $131.2K worth.
What is Paolo Tombesi's Past Insider Trading?
Paolo Tombesi's largest sale order was 1,805 units , worth over $29.15K on June 30, 2020. In total, Paolo Tombesi has made about 8 transactions over 2 years of their time at Epizyme, Inc. Paolo Tombesi usually trades in February, with the busiest year in 2020. The most recent transaction was a sale order of 1,021 units , worth over $11.45K on February 5, 2021.
PAOLO TOMBESI
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Paolo Tombesi's Salary in 2020?
As Chief Financial Officer of Epizyme, Inc, Paolo Tombesi has a total base salary of $460,000 . Paolo Tombesi received compensation valued at about $1,683,734 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of restricted stock awards of $250,006 , option awards of $750,730 , other earnings, plans or compensations of $174,800 , and other compensation of $48,198 .
What is Paolo Tombesi's' Mailing Address?
- Mailing address is 10 Finderne Avenue Building 10 Bridgewater NJ 08807 NJ
Epizyme, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Restricted Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Robert B. Bazemore Jr. | 2020 | $650,000 | - | $3,237,620 | $4,103,853 | $370,500 | $96,369 | $8,458,342 |
| Robert B. Bazemore Jr. | 2019 | $592,937 | - | $1,105,393 | $2,060,531 | $409,127 | $5,630 | $4,173,618 |
| Robert B. Bazemore Jr. | 2018 | $575,667 | - | - | $2,748,939 | $320,575 | $5,690 | $3,650,871 |
| Paolo Tombesi | 2020 | $460,000 | - | $250,006 | $750,730 | $174,800 | $48,198 | $1,683,734 |
| Paolo Tombesi | 2019 | $168,901 | - | $612,848 | $1,173,669 | $76,076 | $146,971 | $2,178,465 |
| Matthew E. Ros | 2020 | $447,982 | - | $250,006 | $750,730 | $174,800 | $11,271 | $1,634,789 |
| Matthew E. Ros | 2019 | $432,600 | - | $538,793 | $899,137 | $199,861 | $11,598 | $2,081,989 |
| Matthew E. Ros | 2018 | $420,000 | - | - | $1,099,576 | $187,100 | $12,214 | $1,718,890 |
| Dr. Shefali Agarwal | 2020 | $478,000 | - | $274,990 | $825,799 | $199,804 | $7,154 | $1,785,747 |
| Dr. Shefali Agarwal | 2019 | $463,500 | - | $894,607 | $1,255,325 | $265,122 | $8,652 | $2,887,206 |
| Dr. Shefali Agarwal | 2018 | $199,615 | $125,000 | - | $1,472,846 | $200,500 | $1,648 | $1,999,609 |
| Jeffery L. Kutok, M.D., Ph.D. | 2020 | $337,500 | $85,000 | $374,996 | $1,124,996 | $134,663 | $6,813 | $2,063,968 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1571498/000119312521138283/d839557ddef14a.htm
What are Epizyme, Inc's Past Insider Trades?
Epizyme, Inc's most recent insider trade came on April 13, 2022 by Jeffery Kutok who sold 2,741 units worth $2.47K . In the last 9 years, insiders at Epizyme, Inc have sold an estimated value of $156.28M and bought an estimated value of $381.12M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are David Mott, Director, Robert Copeland, President Research and CSO, and Andrew Singer, EVP & CFO .
Epizyme, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||